Baird Upgrades UnitedHealth Group to Neutral, Raises Price Target to $453

Benzinga Newsdesk www.benzinga.com Positive 89.7%

Neg 0% Neu 0% Pos 89.7%

Baird analyst Michael Ha upgrades UnitedHealth Group (NYSE:UNH) from Underperform to Neutral and raises the price target from $287 to $453.